Loading...
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
OBJECTIVE: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to temozolomide therapy. Given that the IDH status has critical effects on the survival and epigenetic features of glioblastoma, we aimed to...
Na minha lista:
| Udgivet i: | Cancer Biol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Compuscript
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7877176/ https://ncbi.nlm.nih.gov/pubmed/33628600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2020.0179 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|